Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
1.640
+0.350 (27.13%)
At close: Oct 21, 2025, 4:00 PM EDT
1.610
-0.030 (-1.83%)
After-hours: Oct 21, 2025, 7:53 PM EDT
Prelude Therapeutics Market Cap
Prelude Therapeutics has a market cap or net worth of $124.86 million as of October 21, 2025. Its market cap has decreased by -12.91% in one year.
Market Cap
124.86M
Enterprise Value
69.56M
1-Year Change
-12.91%
Ranking
Category
Stock Price
$1.64
Market Cap Chart
Since the IPO on September 25, 2020, Prelude Therapeutics's market cap has decreased from $806.64M to $124.86M, a decrease of -84.52%. That is a compound annual growth rate of -30.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2025 | 98.21M | 1.53% |
| Dec 31, 2024 | 96.73M | -70.04% |
| Dec 29, 2023 | 322.85M | 12.32% |
| Dec 30, 2022 | 287.43M | -50.22% |
| Dec 31, 2021 | 577.35M | -80.97% |
| Dec 31, 2020 | 3.03B | 276.02% |
| Sep 25, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 720.73B |
| Johnson & Johnson | 465.34B |
| AbbVie | 405.55B |
| UnitedHealth Group | 322.96B |
| AstraZeneca | 260.83B |
| Novartis AG | 254.64B |
| Novo Nordisk | 237.72B |
| Abbott Laboratories | 223.72B |